{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:07:13Z","timestamp":1788869233148,"version":"build-2803163510"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Prostate cancer (PCa) is one of the most common malignant tumors in men, and its onset and progression may be closely associated with an imbalance in the gut microbiota. Existing studies indicate that PCa patients exhibit reduced fecal microbiota diversity and altered microbiota composition, with the abundance of certain bacterial genera correlated with disease risk and progression. Mechanistically, the gut microbiota may regulate signaling pathways such as IGF-1, MAPK\/PI3K, and NF-\u03baB through metabolites including short-chain fatty acids, bile acids, and microbiota-derived androgens, thereby potentially contributing to tumor proliferation, inflammatory responses, and immune evasion. Androgen deprivation therapy (ADT) can also reshape the gut microbiota; certain bacterial populations may contribute to the development of castration resistance through androgen metabolism, while changes in bacteria such as\n                    <jats:italic>Akkermansia muciniphila<\/jats:italic>\n                    are associated with treatment response. Currently, strategies such as dietary interventions, probiotics, and fecal microbiota transplantation have shown some promise; however, most existing studies are small-sample or cross-sectional in nature, and causal relationships remain unclear. Future studies should combine multicenter longitudinal cohorts with multi-omics technologies to further elucidate the translational value of the gut microbiota in PCa screening, risk stratification, prognostic assessment, treatment-response prediction, toxicity monitoring, and personalized microbiome-targeted interventions.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2026.1882172","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:11:30Z","timestamp":1788865890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut\u2013prostate axis in prostate cancer: microbiome signatures, mechanistic insights, and therapeutic opportunities"],"prefix":"10.3389","volume":"16","author":[{"given":"Kenan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhen","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanxin","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/pros.23713","article-title":"A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis","volume":"79","author":"Alanee","year":"2019","journal-title":"Prostate"},{"key":"B2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5215\/pennmaghistbio.136.2.0220","article-title":"2022 update on prostate cancer epidemiology and risk factors-a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jmii.2022.12.009","article-title":"C. scindens metabolites trigger prostate cancer progression through androgen receptor signaling","volume":"56","author":"Bui","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuroe.2025.501748","article-title":"Gut microbiota and prostate cancer: An analysis of bacterial communities across various clinical scenarios","volume":"49","author":"Carballo Quinta","year":"2025","journal-title":"Actas. Urol. Esp. (Engl. Ed)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/spc.0000000000000134","article-title":"Probiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to action","volume":"9","author":"Ciorba","year":"2015","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13092105","article-title":"Exploring the intestinal microbiota profile in prostate cancer patients and healthy controls","volume":"13","author":"Cocomazzi","year":"2025","journal-title":"Microorganisms"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1038\/s41467-020-18649-5","article-title":"Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients","volume":"11","author":"Daisley","year":"2020","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109950","article-title":"Microbiome and metabolome dynamics during radiotherapy for prostate cancer","volume":"189","author":"Danckaert","year":"2023","journal-title":"Radiother. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","article-title":"Bacteria in cancer initiation, promotion and progression","volume":"23","author":"El Tekle","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jand.2016.10.017","article-title":"Dietary changes impact the gut microbe composition in overweight and obese men with prostate cancer undergoing radical prostatectomy","volume":"118","author":"Fruge","year":"2018","journal-title":"J. Acad. Nutr. Diet."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2022.104831","article-title":"Microbial community profiling by next-generation DNA sequencing of adenocarcinoma of the prostate with evidence of ochratoxin A producing fungi","volume":"128","author":"Fry","year":"2022","journal-title":"Exp. Mol. Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/cas.16408","article-title":"Comparative analysis of gut microbiota in hormone-sensitive and castration-resistant prostate cancer in Japanese men","volume":"116","author":"Fujimoto","year":"2025","journal-title":"Cancer Sci."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051375","article-title":"The gut-prostate axis: a new perspective of prostate cancer biology through the gut microbiome","volume":"15","author":"Fujita","year":"2023","journal-title":"Cancers (Basel)."},{"key":"B16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","article-title":"The role of gut microbiome in the pathogenesis of prostate cancer: a prospective, pilot study","volume":"111","author":"Golombos","year":"2018","journal-title":"Urology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mnfr.200900152","article-title":"Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice","volume":"54","author":"Gonzalez-Sarrias","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1451045","article-title":"The role of short-chain fatty acid metabolism in the pathogenesis, diagnosis and treatment of cancer","volume":"14","author":"Hou","year":"2024","journal-title":"Front. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/or.2024.8730","article-title":"Butyrate increases methylglyoxal production through regulation of the JAK2\/Stat3\/Nrf2\/Glo1 pathway in castration-resistant prostate cancer cells","volume":"51","author":"Hsia","year":"2024","journal-title":"Oncol. Rep."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18050804","article-title":"Anticancer effect of icaritin on prostate cancer via regulating abundance of Akkermansiaceae and vitamin K2 in intestinal fecal","volume":"18","author":"Hu","year":"2026","journal-title":"Cancers (Basel)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12885-024-12018-x","article-title":"Gut microbiota in patients with prostate cancer: a systematic review and meta-analysis","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105246","article-title":"Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients","volume":"106","author":"Iacovacci","year":"2024","journal-title":"EBioMedicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/pros.70109","article-title":"Androgen-deprivation therapy and dietary habits influence the gut microbial environment in patients with high-risk localized prostate cancer","volume":"86","author":"Ishida","year":"2026","journal-title":"Prostate"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215417","article-title":"Androgen receptor signaling in prostate cancer and therapeutic strategies","volume":"13","author":"Jacob","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"20727","DOI":"10.1002\/cam4.6636","article-title":"Association between gut microbial change and acute gastrointestinal toxicity in patients with prostate cancer receiving definitive radiation therapy","volume":"12","author":"Jang","year":"2023","journal-title":"Cancer Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.euros.2024.02.004","article-title":"Differences in gut microbiota profiles and microbiota steroid hormone biosynthesis in men with and without prostate cancer","volume":"62","author":"Kalinen","year":"2024","journal-title":"Eur. Urol. Open Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/bco2.104","article-title":"Characterization of fecal microbiome in biopsy positive prostate cancer patients","volume":"3","author":"Katz","year":"2022","journal-title":"BJUI. Compass."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2139\/ssrn.3829647","article-title":"Gut environment changes due to androgen deprivation therapy in patients with prostate cancer","volume":"26","author":"Kure","year":"2023","journal-title":"Prostate. Cancer Prostatic. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.molmed.2025.03.015","article-title":"New insights into gut microbiota-prostate cancer crosstalk","volume":"31","author":"Laaraj","year":"2025","journal-title":"Trends Mol. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1038\/s41467-024-45332-w","article-title":"The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids","volume":"15","author":"Lachance","year":"2024","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1243390","article-title":"The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer","volume":"10","author":"Li","year":"2023","journal-title":"Front. Nutr."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.863407","article-title":"Messengers from the gut: gut microbiota-derived metabolites on host regulation","volume":"13","author":"Li","year":"2022","journal-title":"Front. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000038825","article-title":"The role of gut microbiota in prostate cancer progression: A Mendelian randomization study of immune mediation","volume":"103","author":"Li","year":"2024","journal-title":"Med. (Baltimore)."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41391-021-00360-1","article-title":"A cross-sectional study on gut microbiota in prostate cancer patients with prostatectomy or androgen deprivation therapy","volume":"24","author":"Li","year":"2021","journal-title":"Prostate. Cancer Prostatic. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/07853890.2022.2069853","article-title":"Weight loss via a low-carbohydrate diet improved the intestinal permeability marker, zonulin, in prostate cancer patients","volume":"54","author":"Lin","year":"2022","journal-title":"Ann. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1038\/s41388-024-03073-6","article-title":"Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models","volume":"43","author":"Lin","year":"2024","journal-title":"Oncogene"},{"key":"B38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","article-title":"Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer","volume":"74","author":"Liss","year":"2018","journal-title":"Eur. Urol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/pros.23760","article-title":"Combined maternal and post-weaning high fat diet inhibits male offspring's prostate cancer tumorigenesis in transgenic adenocarcinoma of mouse prostate model","volume":"79","author":"Liu","year":"2019","journal-title":"Prostate"},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.32604\/or.2025.072661","article-title":"Gut associated metabolites enhance PD-L1 blockade efficacy in prostate cancer","volume":"34","author":"Liu","year":"2026","journal-title":"Oncol. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.prnil.2024.11.004","article-title":"Sex hormones, blood metabolites and proteins mediating the causal associations between gut microbiota and prostatic diseases: evidences from Mendelian randomization study","volume":"13","author":"Liu","year":"2025","journal-title":"Prostate. Int."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100928","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization","volume":"43","author":"Liu","year":"2023","journal-title":"Neoplasia"},{"key":"B43","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/pros.24903","article-title":"Muscadine grape skin extract in biochemically recurrent prostate cancer: a randomized, placebo-controlled, biomarker-enriched trial in patients with the SOD2 Ala\/Ala variant","volume":"85","author":"Mandl","year":"2025","journal-title":"Prostate"},{"key":"B44","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ijc.34028","article-title":"High-fat diet promotes prostate cancer growth through histamine signaling","volume":"151","author":"Matsushita","year":"2022","journal-title":"Int. J. Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1158\/0008-5472.can-20-4090","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling","volume":"81","author":"Matsushita","year":"2021","journal-title":"Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1111\/cas.14998","article-title":"The gut microbiota associated with high-Gleason prostate cancer","volume":"112","author":"Matsushita","year":"2021","journal-title":"Cancer Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00394-019-02016-2","article-title":"Urolithin A induces prostate cancer cell death in p53-dependent and in p53-independent manner","volume":"59","author":"Mohammed Saleem","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100822","article-title":"Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)","volume":"32","author":"Peiffer","year":"2022","journal-title":"Neoplasia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.abf8403","article-title":"Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis","volume":"374","author":"Pernigoni","year":"2021","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms14010251","article-title":"Diet-microbiome relationships in prostate-cancer survivors with prior androgen deprivation-therapy exposure and previous exercise intervention enrollment","volume":"14","author":"Raber","year":"2026","journal-title":"Microorganisms"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.1158\/1078-0432.ccr-12-3580","article-title":"Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein","volume":"19","author":"Reis","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0087-z","article-title":"Reagent and laboratory contamination can critically impact sequence-based microbiome analyses","volume":"12","author":"Salter","year":"2014","journal-title":"BMC Biol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042214","article-title":"Specific gut microbial environment in lard diet-induced prostate cancer development and progression","volume":"23","author":"Sato","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nm.4185","article-title":"Signals from the gut microbiota to distant organs in physiology and disease","volume":"22","author":"Schroeder","year":"2016","journal-title":"Nat. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification","volume":"27","author":"Shore","year":"2024","journal-title":"Prostate. Cancer Prostatic. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3920\/bm2020.0098","article-title":"Gut microbial differences in breast and prostate cancer cases from two randomised controlled trials compared to matched cancer-free controls","volume":"12","author":"Smith","year":"2021","journal-title":"Benef. Microbes"},{"key":"B59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/a-0755-7715","article-title":"The activity of urolithin A and M4 valerolactone, colonic microbiota metabolites of polyphenols, in a prostate cancer in vitro model","volume":"85","author":"Stanislawska","year":"2019","journal-title":"Planta. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.phymed.2018.03.054","article-title":"The effects of urolithins on the response of prostate cancer cells to non-steroidal antiandrogen bicalutamide","volume":"46","author":"Stanislawska","year":"2018","journal-title":"Phytomedicine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1055\/s-0032-1320956","article-title":"Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion","volume":"27","author":"Stolarczyk","year":"2013","journal-title":"Phytother. Res."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004191","article-title":"Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer","volume":"10","author":"Terrisse","year":"2022","journal-title":"J. ImmunoTher. Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.euo.2025.10.003","article-title":"Increasing phytochemical-rich foods and Lactobacillus probiotics in men with low-risk prostate cancer-a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Thomas","year":"2026","journal-title":"Eur. Urol. Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1136\/gutjnl-2021-326264","article-title":"Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes","volume":"71","author":"Ting","year":"2022","journal-title":"Gut"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112676","article-title":"Exploring the association between gut and urine microbiota and prostatic disease including benign prostatic hyperplasia and prostate cancer using 16S rRNA sequencing","volume":"10","author":"Tsai","year":"2022","journal-title":"Biomedicines"},{"key":"B66","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41391-023-00723-w","article-title":"Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer","volume":"27","author":"Wang","year":"2024","journal-title":"Prostate. Cancer Prostatic. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41564-025-01979-9","article-title":"An expanded metabolic pathway for androgen production by commensal bacteria","volume":"10","author":"Wang","year":"2025","journal-title":"Nat. Microbiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12672-024-00925-1","article-title":"Causal relationship between gut microbiota and prostate cancer contributes to the gut-prostate axis: insights from a Mendelian randomization study","volume":"15","author":"Wang","year":"2024","journal-title":"Discov. Oncol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2574964","article-title":"Differential circulating fungal microbiome in prostate cancer patients compared to healthy control individuals","volume":"2022","author":"Wang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081549","article-title":"Prostate tissue microbiome in patients with prostate cancer: a systematic review","volume":"16","author":"Ward Grados","year":"2024","journal-title":"Cancers (Basel)."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1250369","article-title":"Effects of gut microbiota on prostatic cancer: a two-sample Mendelian randomization study","volume":"14","author":"Xie","year":"2023","journal-title":"Front. Microbiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-024-03063-2","article-title":"Icaritin-curcumol activates CD8(+) T cells through regulation of gut microbiota and the DNMT1\/IGFBP2 axis to suppress the development of prostate cancer","volume":"43","author":"Xu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41423-021-00661-4","article-title":"Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases","volume":"18","author":"Yang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12885-024-12167-z","article-title":"Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway","volume":"24","author":"You","year":"2024","journal-title":"BMC Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12081653","article-title":"Akkermansia muciniphila metabolite inosine inhibits castration resistance in prostate cancer","volume":"12","author":"Yu","year":"2024","journal-title":"Microorganisms"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1445304","article-title":"Causality investigation among gut microbiota, immune cells, and prostate diseases: a Mendelian randomization study","volume":"15","author":"Yue","year":"2024","journal-title":"Front. Microbiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-kappaB-IL6-STAT3 axis","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1882172\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:11:32Z","timestamp":1788865892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1882172\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":78,"alternative-id":["10.3389\/fcimb.2026.1882172"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1882172","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1882172"}}